Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
J Org Chem ; 74(8): 2942-6, 2009 Apr 17.
Artigo em Inglês | MEDLINE | ID: mdl-19320456

RESUMO

A systematic study of the diastereoselectivity of the radical carboazidation of methylenecyclohexane derivatives is presented. Several substitution patterns leading to a high level of stereocontrol have been identified. Axial attack is the preferred reaction pathway for cyclohexyl radicals, and excellent stereoselectivities can be obtained by introducing an axial substitutent at position 2. In this case, a second equatorial substituent at position 2 may be tolerated without a large detrimental effect on the diastereoselectivity. Finally, a high level of equatorial attack is observed with a very bulky substituent at position 2.

2.
Org Lett ; 7(16): 3521-3, 2005 Aug 04.
Artigo em Inglês | MEDLINE | ID: mdl-16048332

RESUMO

Two new 1-N-iminosugars have been prepared as hexofuranose analogues in an efficient manner by an RCM-based route. Both 3,4-disubstituted pyrrolidines display moderate inhibitory activity against Mycobacterium smegmatis galactan biosynthesis. [structure: see text]


Assuntos
Antibacterianos/síntese química , Imino Furanoses/síntese química , Mycobacterium smegmatis/efeitos dos fármacos , Antibacterianos/química , Antibacterianos/farmacologia , Configuração de Carboidratos , Ciclização , Galactanos/biossíntese , Galactanos/metabolismo , Imino Furanoses/química , Imino Furanoses/farmacologia , Estrutura Molecular
3.
Mol Inform ; 30(10): 873-83, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27468107

RESUMO

UDP-galactopyranose mutase (UGM) is a flavo-enzyme involved in the bacterial cell wall biosynthesis. UGM catalyzes the reversible isomerization of UDP-galactopyranose (UDP-Galp) to UDP-galactofuranose (UDP-Galf). UDP-Galf is the activated precursor of galactofuranose (Galf) residues that are essential components of the cell wall of certain pathogenic bacteria such as Klebsiella pneumoniae and Mycobacterium tuberculosis. Neither UGM nor Galf residues are found in humans, making Galf biosynthesis a potential drug target for developing antibacterial agents. We report the identification of novel inhibitors of UGM by in silico docking of the LeadQuest compound database against UGM from Escherichia coli. The 13 most promising inhibitors were then evaluated against K. pneumonia and M. tuberculosis UGMs by enzyme inhibition studies. Two inhibitors were identified with IC50 values of ∼1 µM and subsequently these compounds were docked into the recently solved X-ray structure of Deinococcus radiodurans UGM. The structure-activity relationships of the initial 13 compounds evaluated as inhibitors are discussed.

4.
Org Biomol Chem ; 2(17): 2418-20, 2004 Sep 07.
Artigo em Inglês | MEDLINE | ID: mdl-15326520
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA